August 16, 2017 4:52 PM ET

Pharmaceuticals

Company Overview of Intra-Cellular Therapies, Inc.

Key Executives for Intra-Cellular Therapies, Inc.

NameBoard RelationshipsTitleAge
Sharon Mates Ph.D.113 RelationshipsCo-Founder, Chairman, CEO & President64
Allen A. Fienberg Ph.D.No RelationshipsCo-Founder & VP of Business Development57
Paul Greengard Ph.D.81 RelationshipsCo-Founder and Chairman of Scientific Advisory Board--
Lawrence J. Hineline CPANo RelationshipsVP of Finance, CFO, Treasurer & Assistant Secretary61
Robert E. Davis Ph.D.No RelationshipsSenior VP & Chief Scientific Officer 66
View More Key Executives

Intra-Cellular Therapies, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sharon Mates Ph.D. 113 RelationshipsIntra-Cellular Therapies, Inc.64
Paul Greengard Ph.D. 81 RelationshipsIntra-Cellular Therapies, Inc.--
Joel S. Marcus J.D., CPA 313 RelationshipsAlexandria Real Estate Equities, Inc.70
Christopher D. Alafi Ph.D. 15 RelationshipsAlafi Capital Company LLC54
Carol A. Tamminga M.D. 35 RelationshipsACADIA Pharmaceuticals Inc.--
View All Board Members

Intra-Cellular Therapies, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee BSRobert L. Van Nostrand39 Relationships3 Executives
Compensation Committee J.D., CPAJoel S. Marcus313 Relationships3 Executives
Nominating Committee Ph.D.Christopher D. Alafi15 Relationships3 Executives
Corporate Governance Committee Ph.D.Christopher D. Alafi15 Relationships3 Executives
Advisory Board M.D.Carol A. Tamminga35 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$681.3K
681.3K
425.2K
Bonus$408.8K
408.8K
425.9K
Total Short Term Compensation$3.4M
3.4M
602.9K
Total Value of Options$1.1M
1.1M
8.2M
Compensation as of Fiscal Year 2016
Intra-Cellular Therapies, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

AstraZeneca PLC Announces Retirement of Bruce Burlington as Non-Executive Director and as a Member of the Audit Committee, the Nomination and Governance Committee and as Chairman of the Science Committee, Effective August 31, 2017
August 16, 2017 6:00 AM ET
The Hydroponics Company Limited Announces Executive Changes; Announces its New Registered Office
August 16, 2017 2:33 AM ET
VANC Pharmaceuticals Inc. Appoints Sherif Guorgui to Board of Directors
August 15, 2017 8:29 PM ET
Avenue Therapeutics, Inc. Announces Executive Changes
August 15, 2017 12:00 PM ET
Revive Therapeutics Ltd. Appoints Ram Subramanian as Scientific Advisor for Cannabinoid Based Therapeutics Targeting Liver Diseases
August 15, 2017 11:36 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intra-Cellular Therapies, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.